Armistice Capital’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-150,000
| Closed | -$6.67K | – | 239 |
|
|
2022
Q2 | $6.67K | Sell |
150,000
-74,000
| -33% | -$3.29K | 0.12% | 92 |
|
|
2022
Q1 | $11.1M | Buy |
+224,000
| New | +$11.1M | 0.21% | 70 |
|
|
2021
Q2 | – | Sell |
-192,000
| Closed | -$8.01M | – | 145 |
|
|
2021
Q1 | $8.01M | Sell |
192,000
-172,000
| -47% | -$7.18M | 0.18% | 81 |
|
|
2020
Q4 | $17M | Sell |
364,000
-308,000
| -46% | -$14.3M | 0.58% | 51 |
|
|
2020
Q3 | $28.5M | Buy |
672,000
+390,000
| +138% | +$16.6M | 1.04% | 35 |
|
|
2020
Q2 | $13.5M | Buy |
+282,000
| New | +$13.5M | 0.59% | 56 |
|